Mereo BioPharma

NCT01116440

A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis

NCT01190475

BGS649 Monotherapy in Moderate to Severe Endometriosis Patients

NCT01200862

Safety and Efficacy of BGS649 in Obese, Hypogonadotropic Hypogonadal Men

NCT01332097

Safety & Efficacy of BCT197A2201 in COPD Patients Presenting With an Exacerbation

NCT01406548

Safety and Efficacy of Multiple Dosing Regimens of BPS804 in Post Menopausal Women With Low Bone Mineral Density

NCT01406977

Dose Escalation Study to Evaluate the Safety and Tolerability of Multiple Infusions of BPS804 in Adults With Hypophosphatasia (HPP)

NCT01336959

Safety & Efficacy of BCT197 in Patients Undergoing Cardiac Surgery

NCT01806610

Study of Safety and Tolerability of BPS804 in Patients With Late-stage Chronic Kidney Disease

NCT02730169

Safety and Efficacy of BGS649 in Male Obese Subjects With Hypogonadotropic Hypogonadism

NCT02700919

Efficacy and Safety of BCT197 in Subjects With Acute Respiratory Exacerbations of Chronic Obstructive Pulmonary Disease

NCT02908074

A 6 Month Safety Extension Study of MBGS205

NCT03118570

A Study in Adult Patients With Type I, III or IV Osteogenesis Imperfecta Treated With BPS804

NCT03216486

An Exploratory Study of BPS804 Treatment in Adult Patients With Type I, III or IV Osteogenesis Imperfecta

NCT03636347

A 12-week Study Treating Participants Who Have alpha1-antitrypsin-related COPD With Alvelestat (MPH966) or Placebo.

NCT03679598

Alvelestat (MPH966) for the Treatment of ALpha-1 ANTitrypsin Deficiency

NCT05312697

Long-term Extension Study of Setrusumab in Adults With Type I, III, or IV Osteogenesis Imperfecta

NCT05715216

EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer